GlassScriptPhysician profile
Alexander L Thacker
NPI 1902152358
$819.64
in general payments reported to CMS, 2019-2025
16 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.00 · 2021: $30.68 · 2022: $165 · 2023: $32.87 · 2024: $217 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $165.21 | 2022 | |
| Abbvie INC. | $152.56 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $69.00 | 2019 | |
| Neurocrine Biosciences, INC. | $66.73 | 2025 | |
| Alexion Pharmaceuticals, INC. | $66.41 | 2024 | Ultomiris |
| Boston Scientific Corporation | $56.15 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Lundbeck LLC | $38.31 | 2024-2025 | Vyepti |
| Pfizer INC. | $35.49 | 2024 | |
| Lilly USA, LLC | $33.31 | 2023-2025 | Olumiant, Zepbound, Mounjaro |
| Biohaven Pharmaceuticals, INC. | $30.68 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.34 | 2025 | Hyqvia |
| Alnylam Pharmaceuticals INC. | $19.73 | 2025 | Onpattro |
| Corcept Therapeutics | $17.51 | 2025 | Korlym |
| Abbott Laboratories | $14.81 | 2024 | Merlin@Home |
| Philips North America LLC | $14.38 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.02 | 2025 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Thacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.